Diabetes and WELLbeing the Netherlands 2
Completed
- Conditions
- diabetes mellitusType 2 diabetes10012653
- Registration Number
- NL-OMON50665
- Lead Sponsor
- Kinetic Analysis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 270
Inclusion Criteria
Type 2 diabetes
Over the age of 18
Able to walk independently for 4 meters, walking aids allowed
Cognitively able to follow instructions and able to understand the Dutch or
English questionnaires.
Able to get up from a chair without assistence
Exclusion Criteria
Suffering from psychiatric problems, or have memory problems
Below the age of 18
Not able to walk independently for 4 meters
Not able to get up form a chair without assistence
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The aim of this study is to decrease HbA1c levels through the use of<br /><br>motivational interviewing and a combined lifestyle intervention. Therefore, the<br /><br>change in HbA1c levels will be the main study parameter.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The effect of the interventions on physical activity will be investigated using<br /><br>the International Physical Activity Questionnaire (IPAQ).<br /><br>The effect of the interventions on eating behaviour will be investigated using<br /><br>the Dutch version of the Dutch Eating Behaviour Questionnaire (NVE).<br /><br>The effect of the interventions on health status will be investigated using the<br /><br>Short Form Health Survey (SF-12).<br /><br>The effect of the interventions on quality of life will be investigated using<br /><br>the European Quality of Life (EQ5D) questionnaire.<br /><br>The effect of the interventions on well-being will be investigated using the<br /><br>abbreviated version of the Illness Perception Questionnaire (IPQ-BR).<br /><br>The effect of the interventions on psychosocial self-efficacy will be<br /><br>investigated using the Diabetes Empowerment Scale-Short Form (DES-SF)</p><br>